Wells Fargo & Company Dr Reddys Laboratories LTD Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Wells Fargo & Company holds 1,314 shares of RDY stock, worth $20,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,314
Previous 1,273 3.22%
Holding current value
$20,840
Previous $96,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$75.41 - $84.21 $3,091 - $3,452
41 Added 3.22%
1,314 $104,000
Q2 2024

Aug 13, 2024
SELL
$68.26 - $76.19 $98,772 - $110,246
-1,447 Reduced 53.2%
1,273 $96,000
Q1 2024

May 10, 2024
SELL
$67.36 - $77.59 $13,472 - $15,518
-200 Reduced 6.85%
2,720 $199,000
Q4 2023

Feb 09, 2024
BUY
$64.27 - $69.9 $771 - $838
12 Added 0.41%
2,920 $203,000
Q3 2023

Nov 13, 2023
SELL
$61.9 - $72.77 $9,656 - $11,352
-156 Reduced 5.09%
2,908 $194,000
Q2 2023

Aug 15, 2023
BUY
$53.34 - $63.11 $83,103 - $98,325
1,558 Added 103.45%
3,064 $193,000
Q1 2023

May 12, 2023
BUY
$51.63 - $56.93 $20,600 - $22,715
399 Added 36.04%
1,506 $85,000
Q4 2022

Feb 13, 2023
SELL
$51.15 - $57.45 $3,836 - $4,308
-75 Reduced 6.35%
1,107 $57,000
Q3 2022

Nov 14, 2022
SELL
$49.9 - $57.32 $9,880 - $11,349
-198 Reduced 14.35%
1,182 $62,000
Q2 2022

Aug 12, 2022
BUY
$49.62 - $58.13 $10,122 - $11,858
204 Added 17.35%
1,380 $76,000
Q1 2022

May 16, 2022
BUY
$48.27 - $65.25 $7,288 - $9,852
151 Added 14.73%
1,176 $66,000
Q4 2021

Feb 14, 2022
SELL
$59.5 - $67.25 $4.31 Million - $4.87 Million
-72,449 Reduced 98.6%
1,025 $67,000
Q3 2021

Nov 15, 2021
SELL
$60.19 - $75.29 $2.24 Million - $2.81 Million
-37,298 Reduced 33.67%
73,474 $4.79 Million
Q2 2021

Aug 16, 2021
SELL
$62.12 - $74.2 $816,940 - $975,804
-13,151 Reduced 10.61%
110,772 $8.14 Million
Q1 2021

May 13, 2021
BUY
$57.98 - $73.08 $3.37 Million - $4.25 Million
58,157 Added 88.43%
123,923 $7.61 Million
Q4 2020

Feb 09, 2021
SELL
$62.61 - $71.29 $1.68 Million - $1.91 Million
-26,819 Reduced 28.97%
65,766 $4.69 Million
Q3 2020

Nov 05, 2020
SELL
$51.39 - $72.41 $995,270 - $1.4 Million
-19,367 Reduced 17.3%
92,585 $6.44 Million
Q2 2020

Aug 13, 2020
SELL
$39.55 - $54.65 $1.55 Million - $2.14 Million
-39,182 Reduced 25.93%
111,952 $5.94 Million
Q1 2020

May 14, 2020
BUY
$34.75 - $45.85 $5.25 Million - $6.93 Million
151,134 New
151,134 $6.1 Million

Others Institutions Holding RDY

# of Institutions
245
Shares Held
23.1M
Call Options Held
12.7K
Put Options Held
6.1K
View Full List

About DR REDDYS LABORATORIES LTD

RDY Quotes by TradingView
  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.63B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email